AlphaFold predicted structure
AMH · P03971

Mean pLDDT
68.6/ 100
Low
560 residues
Confidence breakdown
- Very high(≥ 90)16%
- Confident(70–90)45%
- Low(50–70)15%
- Very low(< 50)25%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
anti-Mullerian hormone
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Differences in sex development
BIALLELIC, autosomal or pseudoautosomalpersistent Mullerian duct syndrome
Persistent Müllerian duct syndrome
genetic non-acquired premature ovarian failure
hereditary disease
polycystic ovary syndrome
obesity disorder
endometriosis
cancer
Obesity
obesity due to melanocortin 4 receptor deficiency
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Anti-Muellerian hormone
The anti-Muellerian hormone (AMH) plays an important role in several reproductive functions (PubMed:14742691, PubMed:34155118, PubMed:3754790, PubMed:8469238). Anti-Muellerian hormone binds and activates AMHR2, its specific type-II receptor, that heterodimerizes with type-I receptors (ACVR1 and BMPR1A) to regulate target gene expression through downstream SMAD protein signal transduction (PubMed:20861221, PubMed:34155118). Produced and secreted by Sertoli cells of the male fetus, anti-Muellerian hormone induces Muellerian duct regression during male fetal sexual differentiation (PubMed:34155118, PubMed:3754790, PubMed:8469238). In female, it is produced by granulosa cells of the preantral and small antral follicles and acts as a negative regulator of the primordial to primary follicle transition and decreases FSH sensitivity of growing follicles (PubMed:14742691). Also plays a role in Leydig cell differentiation and function (By similarity)
AMH · P03971

Mean pLDDT
68.6/ 100
Low
560 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0